BRPI0920446A2 - método para fabricar um extrato de fruta da família solanaceae, e, extrato de fruta - Google Patents

método para fabricar um extrato de fruta da família solanaceae, e, extrato de fruta

Info

Publication number
BRPI0920446A2
BRPI0920446A2 BRPI0920446A BRPI0920446A BRPI0920446A2 BR PI0920446 A2 BRPI0920446 A2 BR PI0920446A2 BR PI0920446 A BRPI0920446 A BR PI0920446A BR PI0920446 A BRPI0920446 A BR PI0920446A BR PI0920446 A2 BRPI0920446 A2 BR PI0920446A2
Authority
BR
Brazil
Prior art keywords
fruit extract
making
solanaceae family
solanaceae
family
Prior art date
Application number
BRPI0920446A
Other languages
English (en)
Inventor
Niamh O'kennedy
Original Assignee
Provexis Natural Produts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provexis Natural Produts Ltd filed Critical Provexis Natural Produts Ltd
Publication of BRPI0920446A2 publication Critical patent/BRPI0920446A2/pt
Publication of BRPI0920446B1 publication Critical patent/BRPI0920446B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
BRPI0920446-6A 2008-10-31 2009-11-02 Método para fabricar um extrato de fruta da família solanaceae, e, uso de um extrato de fruta BRPI0920446B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0819959.8A GB0819959D0 (en) 2008-10-31 2008-10-31 Fruit extracts
GB0819959.8 2008-10-31
PCT/GB2009/002593 WO2010049707A2 (en) 2008-10-31 2009-11-02 Fruit extracts

Publications (2)

Publication Number Publication Date
BRPI0920446A2 true BRPI0920446A2 (pt) 2015-12-22
BRPI0920446B1 BRPI0920446B1 (pt) 2024-03-05

Family

ID=40138109

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920446-6A BRPI0920446B1 (pt) 2008-10-31 2009-11-02 Método para fabricar um extrato de fruta da família solanaceae, e, uso de um extrato de fruta

Country Status (19)

Country Link
US (4) US20110206794A1 (pt)
EP (4) EP3607960B1 (pt)
JP (4) JP2012506901A (pt)
KR (5) KR102403082B1 (pt)
CN (1) CN102271697B (pt)
AU (2) AU2009309496B2 (pt)
BR (1) BRPI0920446B1 (pt)
CA (1) CA2742213A1 (pt)
DK (1) DK2349303T3 (pt)
ES (2) ES2829974T3 (pt)
GB (1) GB0819959D0 (pt)
HU (1) HUE033986T2 (pt)
IL (1) IL212579B (pt)
MX (1) MX2011004531A (pt)
NZ (1) NZ592227A (pt)
PH (2) PH12015500810B1 (pt)
PL (4) PL4218783T3 (pt)
PT (1) PT2349303T (pt)
WO (1) WO2010049707A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
EP2791158A4 (en) * 2011-12-16 2015-07-01 Quebec Centre Rech Ind PROCESS FOR EXTRACTION OF ANTHOCYANINE DERIVATIVES FROM A VEGETABLE SOURCE
CN104363774A (zh) * 2012-04-23 2015-02-18 奥斯陆大学 番茄提取物用作抗高血压剂的用途以及制造水溶性无糖番茄提取物的方法
CN102796746B (zh) * 2012-08-07 2014-02-19 山东农业大学 一种调节茄科类黄酮和咖啡酰奎尼酸合成的基因片段及其应用
GB201223365D0 (en) * 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
EP2948005B1 (en) * 2013-01-22 2020-07-15 Lycored Ltd. Compositions comprising heat-treated clear tomato concentrate
CN103293252B (zh) * 2013-05-09 2015-02-04 杭州师范大学 一种中药的膜富集方法
US9241677B2 (en) 2013-07-02 2016-01-26 MobHealth Corporation Device and methods for assessing, diagnosing, and/or monitoring heart health
WO2015046183A1 (ja) 2013-09-24 2015-04-02 味の素株式会社 糖アミノ酸およびその用途
JP6392043B2 (ja) * 2014-09-11 2018-09-19 キッコーマン株式会社 トマト含有飲食品の呈味改善方法
CN118217345A (zh) 2016-11-02 2024-06-21 普罗维斯天然产物有限公司 防护空气污染的不良影响的水溶性番茄提取物
CN107843665A (zh) * 2017-11-01 2018-03-27 汤臣倍健股份有限公司 一种腺苷含量的测定方法及其应用
CN111529711A (zh) * 2020-05-06 2020-08-14 湖南科诺康美生命科技有限公司 一种抗血小板聚集的芦荟提取物及其在prp制备中的应用
GB202208323D0 (en) 2022-06-07 2022-07-20 Provexis Natural Products Ltd Compostions
CN115611728A (zh) * 2022-09-06 2023-01-17 浙江工业大学 一种结合态酚酸释放的超声波方法
CN115645337B (zh) * 2022-12-23 2023-06-02 汤臣倍健股份有限公司 植物提取物组合物及其应用
KR102906986B1 (ko) * 2023-02-09 2026-01-02 서원대학교 산학협력단 성인병 예방 및 음용성이 우수한 산딸기 고농축 음료의 제조 방법
CN116803404B (zh) * 2023-08-24 2023-12-15 汤臣倍健股份有限公司 水溶性番茄浓缩物在制备减少脱发、育发的产品中的应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6467173A (en) * 1987-09-04 1989-03-13 Sanei Kagaku Kogyo Kk Preparation of vegetable or fruit juices
JP2722670B2 (ja) 1989-05-30 1998-03-04 ライオン株式会社 高血圧症予防用飲食品及びその製造方法
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
DE19720767A1 (de) 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen
GB9808796D0 (en) 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
DE69907342T2 (de) * 1998-09-02 2004-03-25 Unilever N.V. Mit beta-cyclocitral angereicherte Tomatenprodukte
AU5965399A (en) 1998-10-12 2000-05-01 Andreas Bockelmann Pharmaceutically active composition
CN1352941A (zh) 2000-11-11 2002-06-12 吉建军 亚油酸胶囊
US20040191790A1 (en) * 2001-05-04 2004-09-30 Tomassen Monica Magdalena Maria Novel regulatory protein
DE10300049A1 (de) 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
ITMI20020632A1 (it) * 2002-03-27 2003-09-29 Indena Spa Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene
KR20050073611A (ko) 2002-11-06 2005-07-14 카오카부시키가이샤 혈액 유동성 개선제
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク． 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
JP4571783B2 (ja) 2003-04-14 2010-10-27 林原 健 抗微生物剤
US20040223962A1 (en) * 2003-05-07 2004-11-11 Riordan Neil H. Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
EP1481669A1 (en) 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
ES2322757T3 (es) * 2003-08-21 2009-06-26 Nestec S.A. Concentrado natural de licopeno y procedimiento de obtencion.
CN1234387C (zh) * 2004-01-12 2006-01-04 李迺灿 一种具有清肺功能的组合物及其制备方法
FR2871378B1 (fr) 2004-06-15 2007-03-30 Seppic Sa Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens
EP1640001A1 (en) 2004-09-24 2006-03-29 New Pharma Investments Holding Composition against cardiovascular diseases
CN100488535C (zh) 2004-12-09 2009-05-20 郭富凤 一种番茄红素混合物
US7419960B2 (en) * 2005-01-07 2008-09-02 Hong Kong Baptist University Hemiterpene glycosides with anti-platelet aggregation activities from Ilex pubescens
GB0502985D0 (en) * 2005-02-14 2005-03-16 Provexis Ltd Therapeutic uses of tomato extracts
WO2006094120A2 (en) 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
JP4260158B2 (ja) * 2005-07-07 2009-04-30 長谷川香料株式会社 トマトジュース濃縮物の製造方法およびトマト風味組成物
AT503521A1 (de) 2006-05-05 2007-11-15 Omnica Gmbh Verwendung eines extraktes von kiwi-frucht
GB0610790D0 (en) * 2006-06-02 2006-07-12 Provexis Natural Products Ltd Therapeutic uses of tomato extracts
US20080009449A1 (en) * 2006-07-07 2008-01-10 Kailash Prasad Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
WO2008080162A2 (en) 2006-12-22 2008-07-03 The Johns Hopkins University Anti-cholesterolemic compounds and methods of use
WO2008131047A2 (en) 2007-04-16 2008-10-30 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
GB0819958D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
CN104363774A (zh) * 2012-04-23 2015-02-18 奥斯陆大学 番茄提取物用作抗高血压剂的用途以及制造水溶性无糖番茄提取物的方法
GB201223365D0 (en) * 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions

Also Published As

Publication number Publication date
JP2018030888A (ja) 2018-03-01
EP3607960B1 (en) 2023-04-12
KR102403082B1 (ko) 2022-05-30
WO2010049707A2 (en) 2010-05-06
AU2016202312A1 (en) 2016-05-05
CA2742213A1 (en) 2010-05-06
CN102271697B (zh) 2014-04-09
PL2349303T3 (pl) 2017-07-31
KR20110093992A (ko) 2011-08-19
GB0819959D0 (en) 2008-12-10
EP3173088A2 (en) 2017-05-31
PL3607960T3 (pl) 2023-08-21
CN102271697A (zh) 2011-12-07
WO2010049707A9 (en) 2011-11-03
PH12015500810A1 (en) 2017-11-27
KR20190117800A (ko) 2019-10-16
US10973865B2 (en) 2021-04-13
KR102032262B1 (ko) 2019-10-16
PL3173088T3 (pl) 2021-01-25
PT2349303T (pt) 2017-04-11
US20140147537A1 (en) 2014-05-29
EP3607960A1 (en) 2020-02-12
EP4218783B1 (en) 2025-07-30
JP6545237B2 (ja) 2019-07-17
US20210330732A1 (en) 2021-10-28
PL4218783T3 (pl) 2025-12-22
WO2010049707A3 (en) 2011-09-29
JP2015057440A (ja) 2015-03-26
HUE033986T2 (en) 2018-01-29
JP2012506901A (ja) 2012-03-22
ES2621793T3 (es) 2017-07-05
NZ592227A (en) 2013-02-22
AU2009309496B2 (en) 2016-01-21
PH12020500521A1 (en) 2021-10-04
US20180256666A1 (en) 2018-09-13
IL212579B (en) 2021-05-31
EP3173088A3 (en) 2017-08-23
IL212579A0 (en) 2011-07-31
PH12015500810B1 (en) 2022-04-27
US20110206794A1 (en) 2011-08-25
JP7049291B2 (ja) 2022-04-06
ES2829974T3 (es) 2021-06-02
EP2349303A2 (en) 2011-08-03
DK2349303T3 (en) 2017-04-24
EP2349303B1 (en) 2017-01-11
EP4218783A1 (en) 2023-08-02
KR20180049265A (ko) 2018-05-10
EP3173088B1 (en) 2020-09-23
KR20210054006A (ko) 2021-05-12
KR20170010100A (ko) 2017-01-25
AU2016202312B2 (en) 2017-11-02
JP2019172692A (ja) 2019-10-10
KR102246163B1 (ko) 2021-04-29
AU2009309496A1 (en) 2010-05-06
MX2011004531A (es) 2011-05-30
BRPI0920446B1 (pt) 2024-03-05

Similar Documents

Publication Publication Date Title
BRPI0814466A2 (pt) Método.
BR112012002582A2 (pt) método para operar uma lavadora, e, lavadora.
BRPI0822756A2 (pt) sistema de prótese de válvula cardíaca e processo para produzir prótese de válvula cardíaca.
BR112012000882A2 (pt) Preparação cosmética capilar e método para aplicação.
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
HRP20150107T1 (xx) Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola
BRPI1012892A2 (pt) composto, e, composição farmacêutica.
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BRPI0816859A2 (pt) Artigo para fumar, e, método para fabricar um artigo para fumar.
BRPI1011134A2 (pt) turbomáquina.
DK2639234T3 (da) Krystallinsk 6,7-umættet 7-carbamoylmorphinanderivat og fremgangsmåde til fremstilling heraf
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI0916787A2 (pt) artigo, e, método para fabricar um artigo
IT1397663B1 (it) Bocchettone e procedimento per la sua fabbricazione.
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
BR112012007880A2 (pt) aparelho de fabricação para um membro dobrado, método para fabricar um membro dobrado e membro dobrado
BRPI0808032A2 (pt) Processos para preparar hidroxipivalinaldeído e para preparar neopentil glicol.
BR112012004297A2 (pt) concentrado perolado e método para a fabricação do mesmo.
BRPI0924664A2 (pt) eletrodo ,e ,método para construir um eletrodo.
BRPI1007925A2 (pt) método, e aparelho.
BRPI1008484A2 (pt) codificador, decodificador e método para os mesmos
PT2349303T (pt) Extratos de fruto
BR112012003151A2 (pt) composição de revestimento, e, método.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BR112012002611A2 (pt) método para operar uma lavadora, e, lavadora.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: PROVEXIS NATURAL PRODUTS LIMITED (GB)

B25G Requested change of headquarter approved

Owner name: PROVEXIS NATURAL PRODUTS LIMITED (GB)

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/11/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2774 DE 05/03/2024 QUANTO AO TITULAR.

B25G Requested change of headquarter approved

Owner name: PROVEXIS NATURAL PRODUCTS LIMITED (GB)

B25G Requested change of headquarter approved

Owner name: PROVEXIS NATURAL PRODUCTS LIMITED (GB)

B25G Requested change of headquarter approved

Owner name: PROVEXIS NATURAL PRODUCTS LIMITED (GB)